methotrexate breast cancer

Release time ：Dec-22,2024

Methotrexate is a frequently utilized chemotherapy agent in the treatment of breast cancer, functioning by inhibiting the metabolism of folic acid within cells, which in turn halts cell proliferation. However, its administration may lead to various side effects, including nausea, vomiting, oral ulcers, and hair loss.

During the course of methotrexate treatment for breast cancer, patients might experience a range of side effects. Mild side effects such as nausea, vomiting, diarrhea, and oral ulcers can typically be managed by adjusting the medication dosage or employing supportive medications. On the other hand, methotrexate has the potential to induce severe side effects such as bone marrow suppression, liver function impairment, and pulmonary fibrosis. Consequently, regular blood tests and monitoring of organ functions are essential for patients undergoing methotrexate therapy to ensure the drug's safety and efficacy.

For breast cancer patients receiving methotrexate treatment, it is advised to adhere to the physician's instructions, take medication punctually, and vigilantly monitor their health status. Any discomfort should be promptly communicated to the healthcare provider. Moreover, patients are encouraged to maintain healthy lifestyle practices, including a balanced diet, regular exercise, and a positive mental attitude, to enhance treatment outcomes and overall quality of life.